ANKRD22 and metastatic carcinoma: From the results, we identified ANKRD22 (ankyrin repeat domain 22) to be successively up-regulated in adjacent, primary and metastatic carcinoma tissues, and significantly affected tumor growth as a novel tumor-associated gene in NSCLC.